股市必读：维力医疗（603309）2月5日主力资金净流出32.41万元，占总成交额0.43%

Group 1 - The core point of the article is that Weili Medical has received EU MDR certification for multiple products, allowing them to be legally sold in the EU market [1][3]. - On February 5, 2026, Weili Medical's stock closed at 14.57 yuan, with an increase of 1.25% and a trading volume of 52,200 shares, amounting to a total transaction value of 75.83 million yuan [1]. - The net capital flow on February 5 shows a net outflow of 324,100 yuan from main funds, while retail funds experienced a net outflow of 46,400 yuan [1][3]. Group 2 - The products that received EU MDR certification include urinary catheter care kits, drainage bags, puncture guides, nebulizers, and various other medical devices [1]. - The certification was issued by TÜV SÜD Product Service GmbH, with a validity period until May 15, 2028, or December 5, 2028 [1].